Dr. Scarlett’s premier presentation (besides the long forgotten AML mouse presentation with Dr. Lane (Dr. Who?):
https://s201.q4cdn.com/710325604/files/ ... -Event.pdf
It never hurts to review why we are still here and what we are waiting for
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
-
biopearl123
- Posts: 2591
- Joined: Fri Jul 20, 2018 5:13 pm
-
biopearl123
- Posts: 2591
- Joined: Fri Jul 20, 2018 5:13 pm
Re: It never hurts to review why we are still here and what we are waiting for
And yet and yet, here we are 12 years later. I think WTF is a reasonable question at this point. And one that demands a reasonable answer. One we should pose to the new CEO. One can only hope he will meet his shareholders with honesty. Here’s one example. The latest job offering states something about future new products (again). Really? A look into the future could really give us a shot in the arm with the right leadership and vision. And honesty.
-
seedylemon
- Posts: 14
- Joined: Thu Jan 24, 2019 8:57 pm
Re: It never hurts to review why we are still here and what we are waiting for
What a pleasure to read details of the Mayo trial from 2013, short, sweet, and remarkable. Yet it was swept away as I recall because the presiding standard of care for ET was ‘sufficient,’ so there was no need to proceed with a Phase 3 trial. We moved on.
Can we expect that the Phase 3 Impact trial, soon to deliver, will go the way of the Mayo trial?
Can we expect that the Phase 3 Impact trial, soon to deliver, will go the way of the Mayo trial?
-
biopearl123
- Posts: 2591
- Joined: Fri Jul 20, 2018 5:13 pm
Re: It never hurts to review why we are still here and what we are waiting for
Don’t think so. If the trial is positive we will soar. If is meh we will tank. It’s been an interminable wait. Am encouraged by continuing additional extensions.